Stockscreener 앱 받기
1.28
0.00%
0.00
전일 마감가:
$1.28
열려 있는:
$1.28
하루 거래량:
2.35M
Relative Volume:
0.81
시가총액:
$982.66M
수익:
$711.41M
순이익/손실:
$-133.73M
주가수익비율:
-6.7368
EPS:
-0.19
순현금흐름:
$-199.99M
1주 성능:
-5.88%
1개월 성능:
-2.29%
6개월 성능:
-5.88%
1년 성능:
-12.93%
1일 변동 폭
$1.27
$1.30
1주일 범위
$1.27
$1.36
52주 변동 폭
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
OPK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.28 | 982.66M | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | JP Morgan | Neutral |
| 2025-10-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
Options Flow: What is the long term forecast for OPKO Health Inc stockPortfolio Growth Summary & Fast Entry High Yield Tips - baoquankhu1.vn
OPKO Health (NASDAQ:OPK) Shares Cross Below Fifty Day Moving AverageHere's Why - MarketBeat
OPK: Therapeutics-focused strategy, key partnerships, and innovative pipeline drive growth - TradingView — Track All Markets
Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns - Yahoo Finance
Block Trades: Is OPKO Health Inc forming a double bottom2025 AllTime Highs & Accurate Buy Signal Notifications - baoquankhu1.vn
Assessing OPKO Health (OPK) Valuation After Diagnostics Refocus And Mixed Share Price Performance - Yahoo Finance
What are the future prospects of OPKO Health Inc.Exit Point & Smart Allocation Stock Tips - bollywoodhelpline.com
Opko Health, Inc. (OPK) Stock Analysis: Exploring A 167% Potential Upside For Investors - DirectorsTalk Interviews
Bearish Setup: Should I hold or sell OPKO Health Inc nowWeekly Stock Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Is OPKO Health Inc. stock undervalued vs historical averagesQuarterly Trade Summary & Low Risk Investment Opportunities - Улправда
Is OPKO Health Inc. stock vulnerable to regulatory risks2025 Dividend Review & Advanced Technical Analysis Signals - Улправда
Is OPKO Health Inc. stock supported by innovation pipelineShare Buyback & Real-Time Chart Pattern Alerts - Улправда
Why OPKO Health Inc. stock is considered a top pick2025 Fundamental Recap & Weekly Watchlist for Hot Stocks - Улправда
Is OPKO Health Inc. stock attractive for income investorsQuarterly Portfolio Review & Fast Exit/Entry Strategy Plans - Улправда
Setup Watch: Why OPKO Health Inc. stock appeals to analystsTrade Risk Assessment & Weekly High Return Forecasts - Улправда
Does OPKO Health Inc. stock trade at a discount to peersJuly 2025 PreEarnings & Smart Money Movement Alerts - Улправда
How OPKO Health Inc. (XCY) stock trades after earningsEarnings Forecast Updates & Low Entry Cost Investments - Улправда
OPKO Health, Inc. (NASDAQ:OPK) insiders have recently purchased stock and their bets paid off last week as company hit US$1.0b market cap - simplywall.st
Clinical Laboratory Services Market is expected to reach US$ - openPR.com
Why OPKO Health Inc. stock is rated strong buyPrice Gap Trading Strategies & Free Phenomenal Capital Appreciation - bollywoodhelpline.com
What risks investors should watch in OPKO Health Inc. stockSector Rotation Strategies & Big Gains Small Capital - Улправда
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Sahm
OPKO Health bets on RAYALDEE and pipeline progress for 2026 growth - MSN
OPKO Health, Inc. to Participate in 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Opko Health, Inc. (OPK) Investor Outlook: Assessing A Potential 177.99% Upside - DirectorsTalk Interviews
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth - Yahoo Finance
Lab company lays off more workers at N.J. headquarters as Labcorp takes over - MSN
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN
Patterns Watch: Is OPKO Health Inc stock a bargain at current levelsJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - moha.gov.vn
OPKO Health (NASDAQ:OPK) Stock Crosses Below 50 Day Moving AverageHere's Why - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Receives Average Rating of "Hold" from Analysts - MarketBeat
OPKO Health (NASDAQ:OPK) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Aug Breakouts: What risks investors should watch in OPKO Health Inc. stockWeekly Market Summary & Weekly Return Optimization Alerts - Улправда
Why OPKO Health Inc. stock remains a top recommendationJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - Улправда
Panic Selling: Is OPKO Health Inc. stock undervalued vs historical averages2025 Investor Takeaways & Precise Trade Entry Recommendations - ulpravda.ru
Is OPKO Health Inc. stock oversold or undervaluedWeekly Investment Report & Low Drawdown Trading Strategies - ulpravda.ru
Is OPKO Health Inc. stock positioned for long term growthWeekly Stock Analysis & Safe Entry Trade Reports - Улправда
Can OPKO Health Inc. stock withstand economic slowdownEarnings Trend Report & Consistent Profit Alerts - DonanımHaber
Why OPKO Health Inc. stock is trending among retail tradersDip Buying & Short-Term High Return Ideas - Улправда
OPKO Health Earnings Notes - Trefis
Market Recap: Is OPKO Health Inc. stock positioned for long term growthEarnings Recap Report & Risk Managed Investment Strategies - Улправда
OPKO Health (NASDAQ:OPK) Stock Rating Lowered by Wall Street Zen - MarketBeat
Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - MSN
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - sharewise.com
Here's why you should retain OPKO Health stock in your portfolio now - MSN
Shorts Report: Why analysts upgrade OPKO Health Inc stockEarnings Growth Summary & Stock Portfolio Risk Management - BỘ NỘI VỤ
OPKO Health, Inc. (NASDAQ:OPK) Given Average Rating of "Hold" by Brokerages - MarketBeat
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Opko Health Inc 주식 (OPK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
2.51%
0.74%
자본화:
|
볼륨(24시간):